Anna Rossi
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 29
- Cancer Treatment and Pharmacology 16
- Global Cancer Incidence and Screening 3
-
- Breast Cancer Treatment Studies 24
- Co-authors
- Gianni Bonadonna (24 shared papers)Pinuccia Valagussa (20 shared papers)Umberto Veronesi (14 shared papers)Cristina Brambilla (11 shared papers)Gabriele Tancini (9 shared papers)Emilio Bajetta (4 shared papers)Mario De Lena (2 shared papers)R Musumeci (2 shared papers)
In The Last Decade
Anna Rossi
44 papers receiving 2.2k citations
Anna Rossi's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 1.1k
- Oncology 1.2k
- Pathology and Forensic Medicine 383
- Otorhinolaryngology 71
- Pulmonary and Respiratory Medicine 345
Countries citing papers authored by Anna Rossi
This map shows the geographic impact of Anna Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rossi more than expected).
Fields of papers citing papers by Anna Rossi
This network shows the impact of papers produced by Anna Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rossi. The network helps show where Anna Rossi may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Rossi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer Hit paper breakdown → | 1976 | 968 |
| 2 | 1985 | 219 | |
| 3 | 1977 | 186 | |
| 4 | 1998 | 108 | |
| 5 | 1976 | 98 | |
| 6 | 1991 | 98 | |
| 7 | Are surgical adjuvant trials altering the course of breast cancer? | 1978 | 88 |
| 8 | Phase II study of doxorubicin versus epirubicin in advanced breast cancer. | 1986 | 82 |
| 9 | 1981 | 68 | |
| 10 | 2010 | 65 | |
| 11 | 1995 | 43 | |
| 12 | 1986 | 40 | |
| 13 | 1981 | 37 | |
| 14 | 1987 | 35 | |
| 15 | 2012 | 30 | |
| 16 | 2010 | 28 | |
| 17 | 1982 | 27 | |
| 18 | Oophorectomy for advanced carcinoma of the breast. | 1975 | 26 |
| 19 | 1984 | 23 | |
| 20 | 2019 | 18 |
About Anna Rossi
Anna Rossi is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery, having authored 45 papers that have together received 2.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (24 papers), Cancer Treatment and Pharmacology (16 papers), Breast Lesions and Carcinomas (8 papers), Advanced Breast Cancer Therapies (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Lung Cancer Treatments and Mutations (4 papers), Global Cancer Incidence and Screening (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.2k citations), Pathology and Forensic Medicine (383 citations), Otorhinolaryngology (71 citations) and Pulmonary and Respiratory Medicine (345 citations). Anna Rossi has collaborated with scholars based in Italy, France and Belgium. Frequent co-authors include Gianni Bonadonna, Pinuccia Valagussa, Umberto Veronesi, Cristina Brambilla, Gabriele Tancini, Emilio Bajetta, Mario De Lena, R Musumeci, Ercole Brusamolino and Alberto Banfi. Their work appears in journals such as Recent results in cancer research, Cancer, World Journal of Surgery, Breast Cancer Research and Treatment and The Journal of Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.